Jump to navigation
The latest clinical and political news for Australian Cardiologists
Inside Story: Emily Dunn explores a cardiac dilemma.
As long as it's timed to coincide with a vaccination appointment.
But questions remain about the quality of the evidence.
There’s a threshold below which risk of heart disease increases
The lead investigator of the REVISIT-US study talks to Cardiology Update about outcomes beyond clinical trials
Brazilian study overturns conventional wisdom
The MedicineWise initiative led to a sharp rise in aspirin prescribing
There’s plenty of evidence to link the two conditions, says the American Heart Association
She speaks out over a refugee denied medical evacuation despite suspected MI
New recommendations include mandatory screening in all patients over 65
Aussie research finds big differences between warfarin and NOACs
Adding ezetimibe to the mix does not result in better outcomes in acute coronary syndrome
A smartphone game motivates participation in cardiac rehab
It should help doctors and patients make informed decisions.
The CHA2-DS2-VASc leads to too much anticoagulation in low-risk patients, they say.
For cardiologists this year, all roads led to Rome
Widely used risk score puts too many people on anticoagulation therapy
Their latest guidelines call for lifestyle interventions on a population level
Patients feel less tired, but there is no benefit to heart health
ESC 2016 delegates were surprised to hear its use is routine in Australia
Australian Doctor Group is Australia’s premier business to business publisher, delivering the country’s most recognised industry magazines and websites.
Ensure you never miss a big story by signing up for our daily e-newsletter.